Ankerias helps clinicians working with chronic and neuropathic pain better understand neuropathic pain mechanisms and support diagnosis.

Built on real-world health data and AI-assisted insights, our platform supports clinical decision-making across the care pathway from diagnosis to treatment, including identifying patients who may benefit from spinal cord stimulation (SCS), intraoperative support, and treatment optimization.

From diagnosis to personalised treatment in neuropathic pain

Global neuropathic pain

Everyone deserves to live a healthy and pain-free life. Around 1.5 billion individuals globally suffer from chronic pain, with neuropathic pain affecting 7–10% of these cases. Too many are left without adequate care, leading to ongoing suffering, as neuropathic pain is often underdiagnosed in clinical practice.

Ankerias’s solution

Ankerias provides a digital platform for supporting diagnosis and treatment decisions in neuropathic pain.

The platform integrates patient-reported data, physiological signals, and longitudinal monitoring to help clinicians identify pain mechanisms and assess patients more effectively.

By combining real-world health data with AI-assisted analysis, Ankerias enables more informed clinical decisions across the care pathway, supporting both early diagnosis and personalised treatment strategies.

Clinical gap in neuropathic pain

Neuropathic pain is difficult to recognize and diagnose, and many patients do not receive appropriate treatment in time.

Effective therapies such as spinal cord stimulation (SCS) exist, yet the vast majority of eligible patients remain untreated. Up to 95% of patients who could benefit from SCS do not receive it, often due to delays in diagnosis, unclear patient selection, and fragmented care pathways.

Clinical impact

Improving outcomes in neuropathic pain care requires earlier diagnosis and better-informed treatment decisions.

Ankerias supports clinicians across the full care pathway, from diagnosis to treatment selection and optimization, including comprehensive support for spinal cord stimulation (SCS), from identifying suitable patients to intraoperative guidance and long-term therapy optimization.

We have a very strong background in neuroscience, pain research, data analysis, and AI/ML applications.

Meet Team Ankerias

We have a very strong background in neuroscience, pain research, data analysis, and AI/ML applications.

Hanna Viisanen

Founder, CEO
PhD, Adj. Prof. in Physiology

Hanna is the medical backbone of our innovation at Ankerias Oy. She has over 15 years of experience in neuroscience, particularly in pain physiology, pharmacology, and neuromodulation, with a focus on understanding pain mechanisms and improving diagnosis and treatment pathways.

Her significant research work, cited in over 600 publications, showcases her expertise in neuropathic and chronic pain treatment. As the founder of Ankerias Oy, Hanna utilizes her leadership education and project management experience to guide the company’s vision and operations.

Hanna’s passion is to enhance health services and the lives of pain patients by combining healthcare and AI, drawing on her vast network in healthcare, wearable technology, and AI sectors.

Mette Nissen

Medical advisor

MD PhD, Consultant in Neurosurgery,
Kuopio University Hospital

Mette Nissen, a Neurosurgery Specialist at Kuopio University Hospital, has over a decade of expertise in neuromodulation.

At Ankerias, Mette brings not only her clinical expertise but also her unique perspective on applying AI and machine learning in treating patient with chronic pain. Mette’s expertise is crucial as we develop innovative solutions to improve the quality of life of chronic pain patients.

Her involvement in our team reinforces our commitment to providing cutting-edge care and support to patients, utilizing the latest technology in chronic pain treatment.

Riku Tikkanen

Co-founder, CTO
MSc in Computer Science

Riku specializes in machine learning, data analytics, and wearable sensor technology.

At Ankerias, he focuses on developing algorithms for health data analysis and integrating AI to enhance healthcare, supporting diagnosis and clinical decision-making in neuropathic pain. His background includes working with smartwatches and fitness trackers, as well as analyzing and integrating software for health tech devices. This experience in collaborating with physiologists and universities supports the success of Ankerias.

Set to join Ankerias full-time in March 2024, Riku’s technical skills and innovative approach are vital in advancing our mission in healthcare technology.

Muhammad Faran Ayyaz

Founding Software Engineer

MSc in Computer Science

Faran is the Founding Software Engineer at Ankerias, contributing to the development of our platform, web and mobile applications, and cloud infrastructure.

He brings experience in full-stack software engineering, product architecture, backend systems, integrations, and cloud platforms, with a focus on building secure and scalable software from an early stage.

As an early member of the Ankerias team, Faran helps build a strong technical foundation that enables us to move quickly today while scaling reliably as we grow.

Mikko Pitkänen

Financial advisor
Master in Social Sciences

As CFO of Ankerias, Mikko brings strategic financial leadership and deep expertise in startup finance, fundraising, and public-private capital instruments. With a proven track record of securing over €38 million in funding for early-stage ventures and innovation projects, he leads our capital strategy, investor relations, and financial planning.

Beyond fundraising, Mikko shapes Ankerias’ portfolio strategy — aligning financial models with purpose-driven growth. As a trusted partner to both founders and funders, he ensures that Ankerias delivers short-term traction and long-term value. His vision: to make Ankerias the ultimate painkiller — an innovative category-defining solution for our customers and clinical partners.

Tapio Jakobsson

Regulatory affairs and quality advisor
MSc in Technology

Tapio brings extensive experience in medtech and healthtech, supporting Ankerias in navigating regulatory affairs and quality assurance. With deep expertise in MDR, FDA regulations, and ISO 13485, Tapio ensures that Ankerias meets all necessary compliance requirements in a streamlined and efficient manner.

Tapio’s expertise also covers software-based medical devices and AI-driven technologies, including risk management and regulatory pathways for innovative digital health solutions.

Tapio helps Ankerias accelerate market entry while maintaining high-quality standards. The focus is on achieving compliance without unnecessary complexity, allowing the company to concentrate on innovation and growth.

Nitin Williams

AI/ML advisor
PhD, Adj. Prof. in Neuroinformatics University of Helsinki, Visiting researcher Aalto University

Dr. Nitin Williams is an expert in neurophysiological modelling, neuroinformatics, and biomedical signal processing, with 15+ years of experience in leading universities such as the University of Cambridge, UK, and medical technology companies.

At Ankerias, Dr. Williams advises on the development of data-driven approaches to understanding pain mechanisms and supporting personalized treatment, including spinal cord stimulation, drawing on his interdisciplinary background in modelling and data science.

Driven by a passion for applying cutting-edge technology to realize the vision of personalized medicine, he is committed to improving human lives. This mission aligns closely with Ankerias’s goal to transform chronic pain care through innovative and patient-centered solutions.

Alexander Helmut Jung

AI/ML advisor

Associate Professor for ML,
Aalto University

Dr. Alexander Jung is a tenured Associate Professor for Machine Learning at the Department of Computer Science of Aalto University (Finland) where he leads the group Trustworthy Machine Learning from Big Data over Networks.

Dr. Jung serves as advisor to Ankerias with a profound understanding of computational methodologies and their applications in healthcare.

Dr. Jung’s expertise and passion for leveraging machine learning in healthcare exemplify Ankerias’s commitment to pioneering solutions that empower patients and healthcare providers alike in the fight against chronic pain.

Ankerias News

Follow Ankerias and track the progress of our project.

In 2025, we advanced clinical validation through surveys and early pilots while developing our AI-based platform for neuropathic pain and spinal cord stimulation (SCS).

In 2026, our pre-seed round is ongoing with initial investors committed. We are deepening collaboration with research partners and preparing clinical pilots starting in Q2 2026.

Our focus is to advance validation, expand pilots, and begin initial commercial activities.

We are continuing discussions with investors as we build toward our next funding round.

Drop us a message and let’s talk.

Interested to hear more? Contact us.

Ankerias is based in Helsinki, Finland. Let’s organize a meeting so we can look at Ankerias’s solution in detail, face to face or online.

We should discuss how we could collaborate with you and your organization!

Drop us a message!

Name